| CBLI Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CBLI shares outstanding history going back to 1/28/2015:
Also see: CBLI Market Cap History CBLI YTD Return |
CBLI Shares Outstanding History — Cleveland BioLabs Share Count Over Time
As of 8/9/2021 Cleveland BioLabs has 15.48 million CBLI shares outstanding. Investors often track the CBLI shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CBLI share count trends over time, with 30 historical shares outstanding datapoints presented, dating back to 1/28/2015.
| CBLI Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CBLI Historical Shares Outstanding: +29.52% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CBLI Stock Price Chart |
| About Statera Biopharma Inc |
| Cytocom is a biopharmaceutical company. Co.'s product candidate, Entolimod is a Toll-like receptor 5 (TLR5) agonist, which Co. is developing as a medical radiation countermeasure for reducing the risk of death following exposure to potentially lethal irradiation Acute Radiation Syndrome. Co.'s other product candidate, Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand, a secretory non-glycosylated version of entolimod Co. is also developing through its subsidiary, Panacela Labs, Inc. Two randomized, placebo-controlled, dose-ranging studies of Mobilan in men with prostate cancer are ongoing in the Russian Federation. We show 30 historical shares outstanding datapoints in our coverage of CBLI's shares outstanding history. Understanding the changing numbers of CBLI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CBLI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CBLI by allowing them to research CBLI shares outstanding history as well as any other stock in our coverage universe. |
| CBLI Current Stock Quote |
Quotes delayed 20 minutes  Free CBLI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CBLI Share Performance |
| Shares Outstanding Peers |
| Cleveland BioLabs (CBLI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CBM Shares Outstanding History CBMG Shares Outstanding History CBPO Shares Outstanding History CBUS Shares Outstanding History CCCC Shares Outstanding History CCEL Shares Outstanding History CCRN Shares Outstanding History CCXI Shares Outstanding History CDAK Shares Outstanding History CDMO Shares Outstanding History More Healthcare companies » |
CBLI Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
